Herbert Loong: Happy to share that our landscape analysis of KRASG12C mutations in Asia has 5000+ views

Herbert Loong shared a post on LinkedIn:

“Throwback to 2020 when we published our landscape analysis of KRASG12C mutations in Asia involving 11,951 samples across tumour types. Just reminded that we have had 5000+ views. Happy to share.”

KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples

Authors: Herbert Ho-Fung Loong, Nan Du, Chunyan Cheng, Hanqing Lin, Jian Guo, Gen Lin, Mingjiang Li, Tao Jiang, Zhihua Shi, Yanzhi Cui, Xianfeng Jin, Jicheng Yao, Yutong Xing, Ming Yao, Kai Wang, Tony S. K. Mok, Lunxu Liu

Source: Herbert Loong/LinkedIn

More posts by Herbert Loong on oncodaily.com

Dr. Herbert H. F. Loong holds several prominent positions in oncology. He is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).

Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer.